For 0 3 0 3 O
patients 4 12 4 12 O
with 13 17 13 17 O
positive 18 26 18 26 O
Hepatitis 27 36 27 36 B-treatment
C 37 38 37 38 I-treatment
Ab 39 41 39 41 I-treatment
, 41 42 41 42 O
negative 43 51 43 51 O
PCR 52 55 52 55 B-treatment
testing 56 63 56 63 I-treatment
must 64 68 64 68 O
be 69 71 69 71 O
documented 72 82 72 82 O

History 0 7 83 90 O
of 8 10 91 93 O
relevant 11 19 94 102 O
CNS 20 23 103 106 B-chronic_disease
pathology 24 33 107 116 I-chronic_disease
or 34 36 117 119 O
current 37 44 120 127 O
relevant 45 53 128 136 O
CNS 54 57 137 140 O
pathology 58 67 141 150 O
( 68 69 151 152 O
non 69 72 152 155 O
- 72 73 155 156 O
febrile 73 80 156 163 O
seizure 81 88 164 171 B-chronic_disease
disorder 89 97 172 180 I-chronic_disease
requiring 98 107 181 190 O
ongoing 108 115 191 198 O
anti 116 120 199 203 B-treatment
- 120 121 203 204 I-treatment
epileptic 121 130 204 213 I-treatment
medications 131 142 214 225 I-treatment
, 142 143 225 226 O
paresis 144 151 227 234 B-chronic_disease
, 151 152 234 235 O
aphasia 153 160 236 243 B-chronic_disease
, 160 161 243 244 O
cerebrovascular 162 177 245 260 B-chronic_disease
ischemia 178 186 261 269 I-chronic_disease
/ 186 187 269 270 O
hemorrhage 187 197 270 280 B-chronic_disease
, 197 198 280 281 O
severe 199 205 282 288 O
brain 206 211 289 294 B-chronic_disease
injuries 212 220 295 303 I-chronic_disease
, 220 221 303 304 O
dementia 222 230 305 313 B-chronic_disease
, 230 231 313 314 O
cerebellar 232 242 315 325 B-chronic_disease
disease 243 250 326 333 I-chronic_disease
, 250 251 333 334 O
organic 252 259 335 342 B-chronic_disease
brain 260 265 343 348 I-chronic_disease
syndrome 266 274 349 357 I-chronic_disease
, 274 275 357 358 O
psychosis 276 285 359 368 B-chronic_disease
, 285 286 368 369 O
coordination 287 299 370 382 B-chronic_disease
or 300 302 383 385 I-chronic_disease
movement 303 311 386 394 I-chronic_disease
disorder 312 320 395 403 I-chronic_disease
) 320 321 403 404 O

Lansky 0 6 405 411 B-clinical_variable
or 7 9 412 414 I-clinical_variable
Karnofsky 10 19 415 424 I-clinical_variable
performance 20 31 425 436 I-clinical_variable
status 32 38 437 443 I-clinical_variable
score 39 44 444 449 I-clinical_variable
of 45 47 450 452 O
≥ 48 49 453 454 O
50 50 52 455 457 B-lower_bound

Life 0 4 458 462 B-clinical_variable
expectancy 5 15 463 473 I-clinical_variable
of 16 18 474 476 O
≥ 19 20 477 478 O
8 21 22 479 480 B-lower_bound
weeks 23 28 481 486 I-lower_bound

Male 0 4 487 491 B-gender

Must 0 4 492 496 O
not 5 8 497 500 O
be 9 11 501 503 O
receiving 12 21 504 513 O
external 22 30 514 522 B-treatment
beam 31 35 523 527 I-treatment
radiation 36 45 528 537 I-treatment
therapy 46 53 538 545 I-treatment
at 54 56 546 548 O
the 57 60 549 552 O
time 61 65 553 557 O
of 66 68 558 560 O
study 69 74 561 566 O
enrollment 75 85 567 577 O

Negative 0 8 578 586 O
HIV 9 12 587 590 B-chronic_disease
antigen 13 20 591 598 O
and 21 24 599 602 O
antibody 25 33 603 611 O
, 33 34 611 612 O
Hepatitis 35 44 613 622 B-chronic_disease
B 45 46 623 624 I-chronic_disease
surface 47 54 625 632 O
antigen 55 62 633 640 O
and 63 66 641 644 O
Hepatitis 67 76 645 654 B-chronic_disease
C 77 78 655 656 I-chronic_disease
antibody 79 87 657 665 O
within 88 94 666 672 O
3 95 96 673 674 B-upper_bound
months 97 103 675 681 I-upper_bound
prior 104 109 682 687 I-upper_bound
to 110 112 688 690 O
enrollment 113 123 691 701 O

No 0 2 702 704 O
prior 3 8 705 710 B-treatment
genetically 9 20 711 722 I-treatment
modified 21 29 723 731 I-treatment
cell 30 34 732 736 I-treatment
therapy 35 42 737 744 I-treatment
that 43 47 745 749 O
is 48 50 750 752 O
still 51 56 753 758 O
detectable 57 67 759 769 O
or 68 70 770 772 O
prior 71 76 773 778 B-treatment
virotherapy 77 88 779 790 I-treatment

No 0 2 791 793 O
systemic 3 11 794 802 B-treatment
corticosteroids 12 27 803 818 I-treatment
( 28 29 819 820 O
unless 29 35 820 826 O
physiologic 36 47 827 838 O
replacement 48 59 839 850 O
dosing 60 66 851 857 O
) 66 67 857 858 O
within 68 74 859 865 O
7 75 76 866 867 B-upper_bound
days 77 81 868 872 I-upper_bound
of 82 84 873 875 O
enrollment 85 95 876 886 O

Patient 0 7 887 894 O
must 8 12 895 899 O
NOT 13 16 900 903 O
have 17 21 904 908 O
received 22 30 909 917 O
a 31 32 918 919 O
prior 33 38 920 925 B-treatment
allogeneic 39 49 926 936 I-treatment
hematopoietic 50 63 937 950 I-treatment
stem 64 68 951 955 I-treatment
cell 69 73 956 960 I-treatment
transplant 74 84 961 971 I-treatment

Patients 0 8 972 980 O
may 9 12 981 984 O
have 13 17 985 989 O
CNS 18 21 990 993 B-cancer
intracranial 22 34 994 1006 I-cancer
tumor 35 40 1007 1012 I-cancer

Patients 0 8 1013 1021 O
who 9 12 1022 1025 O
received 13 21 1026 1034 O
stem 22 26 1035 1039 B-treatment
cell 27 31 1040 1044 I-treatment
infusion 32 40 1045 1053 I-treatment
following 41 50 1054 1063 O
non 51 54 1064 1067 B-treatment
- 54 55 1067 1068 I-treatment
myelo 55 60 1068 1073 I-treatment
- 60 61 1073 1074 I-treatment
ablative 61 69 1074 1082 I-treatment
therapy 70 77 1083 1090 I-treatment

Pregnant 0 8 1091 1099 B-pregnancy

Presence 0 8 1100 1108 O
of 9 11 1109 1111 O
a 12 13 1112 1113 O
primary 14 21 1114 1121 O
immunodeficiency 22 38 1122 1138 B-chronic_disease
/ 38 39 1138 1139 O
bone 39 43 1139 1143 B-chronic_disease
marrow 44 50 1144 1150 I-chronic_disease
failure 51 58 1151 1158 I-chronic_disease
syndrome 59 67 1159 1167 I-chronic_disease

Presence 0 8 1168 1176 O
of 9 11 1177 1179 O
active 12 18 1180 1186 B-cancer
malignancy 19 29 1187 1197 I-cancer
other 30 35 1198 1203 O
than 36 40 1204 1208 O
NB 41 43 1209 1211 B-cancer

Presence 0 8 1212 1220 O
of 9 11 1221 1223 O
active 12 18 1224 1230 O
severe 19 25 1231 1237 B-chronic_disease
infection 26 35 1238 1247 I-chronic_disease

Presence 0 8 1248 1256 O
of 9 11 1257 1259 O
any 12 15 1260 1263 O
concurrent 16 26 1264 1274 O
medical 27 34 1275 1282 O
condition 35 44 1283 1292 O
that 45 49 1293 1297 O
, 49 50 1297 1298 O
in 51 53 1299 1301 O
the 54 57 1302 1305 O
opinion 58 65 1306 1313 O
of 66 68 1314 1316 O
the 69 72 1317 1320 O
protocol 73 81 1321 1329 O
PI 82 84 1330 1332 O
or 85 87 1333 1335 O
designee 88 96 1336 1344 O
, 96 97 1344 1345 O
would 98 103 1346 1351 O
prevent 104 111 1352 1359 O
the 112 115 1360 1363 O
patient 116 123 1364 1371 O
from 124 128 1372 1376 O
undergoing 129 139 1377 1387 O
protocol 140 148 1388 1396 B-treatment
- 148 149 1396 1397 I-treatment
based 149 154 1397 1402 I-treatment
therapy 155 162 1403 1410 I-treatment

Presence 0 8 1411 1419 O
of 9 11 1420 1422 O
known 12 17 1423 1428 O
intracranial 18 30 1429 1441 B-chronic_disease
metastatic 31 41 1442 1452 I-chronic_disease
neuroblastoma 42 55 1453 1466 I-chronic_disease

Prior 0 5 1467 1472 O
diagnosis 6 15 1473 1482 O
of 16 18 1483 1485 O
NB 19 21 1486 1488 B-cancer
or 22 24 1489 1491 I-cancer
ganglioneuroblastoma 25 45 1492 1512 I-cancer
either 46 52 1513 1519 O
by 53 55 1520 1522 O
histologic 56 66 1523 1533 O
verification 67 79 1534 1546 O
and/or 80 86 1547 1553 O
demonstration 87 100 1554 1567 O
of 101 103 1568 1570 O
tumor 104 109 1571 1576 B-cancer
cells 110 115 1577 1582 O
in 116 118 1583 1585 O
the 119 122 1586 1589 O
bone 123 127 1590 1594 O
marrow 128 134 1595 1601 O
with 135 139 1602 1606 O
increased 140 149 1607 1616 O
catecholamine 150 163 1617 1630 O
levels 164 170 1631 1637 O

Receiving 0 9 1638 1647 O
any 10 13 1648 1651 O
other 14 19 1652 1657 O
anti 20 24 1658 1662 B-treatment
- 24 25 1662 1663 I-treatment
cancer 25 31 1663 1669 I-treatment
agents 32 38 1670 1676 I-treatment
or 39 41 1677 1679 O
radiotherapy 42 54 1680 1692 B-treatment
at 55 57 1693 1695 O
the 58 61 1696 1699 O
time 62 66 1700 1704 O
of 67 69 1705 1707 O
study 70 75 1708 1713 O
entry 76 81 1714 1719 O

Recovered 0 9 1720 1729 O
from 10 14 1730 1734 O
significant 15 26 1735 1746 O
acute 27 32 1747 1752 O
toxic 33 38 1753 1758 O
effects 39 46 1759 1766 O
of 47 49 1767 1769 O
all 50 53 1770 1773 O
prior 54 59 1774 1779 O
chemotherapy 60 72 1780 1792 B-treatment
, 72 73 1792 1793 O
immunotherapy 74 87 1794 1807 B-treatment
, 87 88 1807 1808 O
or 89 91 1809 1811 O
radiotherapy 92 104 1812 1824 B-treatment
prior 105 110 1825 1830 O
to 111 113 1831 1833 O
enrollment 114 124 1834 1844 O
onto 125 129 1845 1849 O
this 130 134 1850 1854 O
study 135 140 1855 1860 O

Skull 0 5 1861 1866 B-cancer
based 6 11 1867 1872 I-cancer
disease 12 19 1873 1880 I-cancer
with 20 24 1881 1885 O
soft 25 29 1886 1890 O
tissue 30 36 1891 1897 O
extension 37 46 1898 1907 O

Unable 0 6 1908 1914 O
to 7 9 1915 1917 O
tolerate 10 18 1918 1926 O
apheresis 19 28 1927 1936 B-treatment
procedure 29 38 1937 1946 O
including 39 48 1947 1956 O
placement 49 58 1957 1966 O
of 59 61 1967 1969 O
temporary 62 71 1970 1979 O
apheresis 72 81 1980 1989 B-treatment
catheter 82 90 1990 1998 I-treatment

female 0 6 1999 2005 B-gender
subjects 7 15 2006 2014 I-gender

≤ 0 1 2015 2016 O
26 2 4 2017 2019 B-upper_bound
years 5 10 2020 2025 I-upper_bound
of 11 13 2026 2028 O
age 14 17 2029 2032 B-age

≥ 0 1 2033 2034 O
12 2 4 2035 2037 B-lower_bound
weeks 5 10 2038 2043 I-lower_bound
from 11 15 2044 2048 O
prior 16 21 2049 2054 B-treatment
I131 22 26 2055 2059 I-treatment
MIBG 27 31 2060 2064 I-treatment
therapy 32 39 2065 2072 I-treatment

≥ 0 1 2073 2074 O
3 2 3 2075 2076 B-lower_bound
half 4 8 2077 2081 I-lower_bound
- 8 9 2081 2082 I-lower_bound
lives 9 14 2082 2087 I-lower_bound
or 15 17 2088 2090 O
30 18 20 2091 2093 B-lower_bound
days 21 25 2094 2098 I-lower_bound
from 26 30 2099 2103 O
time 31 35 2104 2108 O
of 36 38 2109 2111 O
last 39 43 2112 2116 O
dose 44 48 2117 2121 O
of 49 51 2122 2124 O
anti 52 56 2125 2129 B-treatment
- 56 57 2129 2130 I-treatment
tumor 57 62 2130 2135 I-treatment
directed 63 71 2136 2144 I-treatment
antibody 72 80 2145 2153 I-treatment
therapy 81 88 2154 2161 I-treatment
, 88 89 2161 2162 O
whichever 90 99 2163 2172 O
is 100 102 2173 2175 O
shorter 103 110 2176 2183 O
from 111 115 2184 2188 O
time 116 120 2189 2193 O
of 121 123 2194 2196 O
enrollment 124 134 2197 2207 O

≥ 0 1 2208 2209 O
6 2 3 2210 2211 B-lower_bound
weeks 4 9 2212 2217 I-lower_bound
from 10 14 2218 2222 O
myeloablative 15 28 2223 2236 B-treatment
therapy 29 36 2237 2244 I-treatment
and 37 40 2245 2248 O
autologous 41 51 2249 2259 B-treatment
stem 52 56 2260 2264 I-treatment
cell 57 61 2265 2269 I-treatment
transplant 62 72 2270 2280 I-treatment
( 73 74 2281 2282 O
timed 74 79 2282 2287 O
from 80 84 2288 2292 O
stem 85 89 2293 2297 B-treatment
cell 90 94 2298 2302 I-treatment
infusion 95 103 2303 2311 I-treatment
) 103 104 2311 2312 O

≥ 0 1 2313 2314 O
7 2 3 2315 2316 B-lower_bound
days 4 8 2317 2321 I-lower_bound
since 9 14 2322 2327 O
last 15 19 2328 2332 O
chemotherapy 20 32 2333 2345 B-treatment
or 33 35 2346 2348 O
biologic 36 44 2349 2357 B-treatment
therapy 45 52 2358 2365 I-treatment
administration 53 67 2366 2380 O

